Home
Clinical Trials
Pneumocystis Jirovecii Pneumo...

Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients

Last Updated: 2023-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

133 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-01

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pneumocystis jirovecii pneumonia (PjP) is a rare infectiouse disease with a high level of mortality. PjP is a classical opportunistic infection which concern HIV infected and immunocompromised patients. During the past decade, several therapeutic's progresses have been done in oncology, immunology and hematology. As a consequence, patients benefited of greater treatment efficacy but are exposed to a higher risk of opportunistic infections as PjP. The investigators hypothesis is that PjP incidence increase and its form is depending of underlying immune conditions. The investigators aim to describe its incidence, the PjP forms depending on comorbidities and to identifiy pronostics factors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pneumocystis in Patients Over 75 Year

NCT07004127

Pneumocystis

COMPLETED

Pneumocystis Pneumonia Diagnosis in HIV- Patients

NCT02648256

Pneumonia, Pneumocystis

UNKNOWN NA

Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients

NCT02944045

Pneumocystis Steroids Immunocompromised Patient +3 more

UNKNOWN PHASE3

Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid

NCT05452148

Transplantation Pulmonary Diseases

COMPLETED

Corticosteroids for PJP in Non-HIV Immunocompromised Adults

NCT07152613

Pneumocystis Jiroveci Pneumonia

NOT_YET_RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumocystis Jirovecii Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Underlying immune condition at risk of Pneumocystis jirovecii pneumonia excluding HIV infection
* Clinical, biological and radiological presentation which evoke Pneumocystis jirovecii pneumonia
* Microbiological confirmation by respiratory specimen analyses ( specific coloration and/or IFI and/or PRC)